본문 바로가기

Xylitol inhibits in vitro and in vivo angiogenesis by suppressing the NF-kappa B and Akt signaling pathways

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q2
저널
INTERNATIONAL JOURNAL OF ONCOLOGY43(1) · pp.315 · 2013
피인용
Web of Science 10
JCR IF
JCR 2012 2.657
ISSN
1019-6439

저자

  1. 이의연제1저자Department of Molecular Biology, College of Natural Science, Pusan National University, South Korea
  2. 김영진교신저자Department of Molecular Biology, College of Natural Science, Pusan National University, South Korea

초록

Angiogenesis is an important process involved in tumor growth and metastasis. Many studies have investigated the use of natural compounds such as angiogenic inhibitors. Xylitol is a 5-carbon sugar alcohol and is an artificial sweetener that has been used in chewing gums to prevent tooth decay. Xylitol has been also known to inhibit inflammatory cytokine expression induced by lipopolysaccharide (LPS). Since angiogenesis and inflammation share a common signaling pathway, we investigated the role of xylitol in angiogenesis. Xylitol inhibited the migration, invasion and tube formation of human umbilical vein endothelial cells (HUVECs). Xylitol also inhibited in vivo angiogenesis in a mouse Matrigel plug assay. Furthermore, mRNA expression of vascular endothelial growth factor (VEGF), VEGFR-II (KDR), basic fibroblast growth factor (bFGF), bFGFR-II, matrix metalloproteinase-2 (MMP-2) and MMP-9 of HUVECs decreased following treatment with xylitol. These anti-angiogenic effects of xylitol are exerted through inhibition of NF-kappa B and Akt activation. Taken together, these results suggest that xylitol acts as a beneficial angiogenesis inhibitor.

키워드

xylitolangiogenesisNF-kappa BAktanticancerENDOTHELIAL GROWTH-FACTORSTREPTOCOCCUS-MUTANSTUMOR ANGIOGENESISCANCER DEVELOPMENTCHEWING GUMSINFLAMMATIONPROGRESSIONCARCINOMASORBITOLXYLOSE

식별자

WoS UID
000321023100037